循证清单延迟脑死亡潜在器官捐献者发生心脏骤停:DONORS整群随机临床试验
DONORS是在巴西63家医院ICU开展的开放标签、平行分组整群随机临床试验,纳入1535例14-90岁脑死亡潜在捐献者。干预组使用包含13项临床目标和14项对应措施的循证清单,每6小时一次,从入组至器官获取;对照组接受常规治疗。主要终点心脏骤停所致捐献者丢失在干预组为9.4%、对照组为14.8%(RR 0.70,95%CI 0.46-1.08,P=0.11)。依从性>79.0%者主要终点发生率5.3%,低于对照组的14.8%(RR 0.41,95%CI 0.22-0.78,P=0.006)。作者认为该试验未能确定清单总体使用是否减少捐献者丢失,不依从推荐措施时清单效果有限。
要点
- 在63家医院1535例脑死亡潜在捐献者中,干预组心脏骤停丢失9.4%(70例)vs 对照组14.8%(117例),RR 0.70(95%CI 0.46-1.08),P=0.11,未达统计学显著。
- 依从性>79.0%者心脏骤停丢失5.3%,低于对照组14.8%,RR 0.41(95%CI 0.22-0.78),P=0.006。
- 干预为每6小时一次使用含13项临床目标和14项对应措施的循证清单,从入组至器官获取。
- 作者认为,不依从清单推荐措施时,该清单效果有限。
- 主要脑损伤病因为卒中(877例,57.1%),其次为创伤(485例,31.6%)。
适用人群与场景
- 巴西63家医院ICU中,既往2年报告10例及以上脑死亡的医院。
- 连续纳入的14至90岁、首次临床检查后符合脑死亡条件的脑死亡潜在捐献者。
处置流程与药物剂量
- 干预组医院工作人员被指导对脑死亡潜在捐献者使用循证清单,清单包含13项临床目标和14项对应措施以指导治疗,每6小时一次,从研究入组至器官获取。
- 对照组提供或接受常规治疗。
研究设计与关键结果
- 开放标签、平行分组整群随机临床试验,在巴西63家医院纳入1535例脑死亡潜在捐献者;31家医院(49.2%)分配至干预组(743例,48.4%),32家(50.8%)分配至对照组(792例,51.6%)。
- 纳入者中男性673例(59.2%),中位(IQR)年龄51(36.3-62.0)岁;主要脑损伤病因为卒中(877例,57.1%),其次为创伤(485例,31.6%)。
- 主要终点心脏骤停所致捐献者丢失:干预组70例(9.4%)vs 对照组117例(14.8%),RR 0.70(95%CI 0.46-1.08),P=0.11。
- 预设敏感性分析:依从性>79.0%者主要终点发生率5.3%,低于对照组14.8%,RR 0.41(95%CI 0.22-0.78),P=0.006。
证据类型、等级与局限
- 研究类型:开放标签、平行分组整群随机临床试验(DONORS)。
- 作者结论:该整群随机临床试验未能确定循证目标导向清单的总体使用是否减少脑死亡潜在捐献者心脏骤停丢失;作者认为,不依从清单推荐措施时,该清单效果有限。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,不依从清单推荐措施时,使用该循证目标导向清单效果有限。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: The effectiveness of goal-directed care to reduce loss of brain-dead potential donors to cardiac arrest is unclear.
OBJECTIVE: To evaluate the effectiveness of an evidence-based, goal-directed checklist in the clinical management of brain-dead potential donors in the intensive care unit (ICU).
DESIGN, SETTING, AND PARTICIPANTS: The Donation Network to Optimize Organ Recovery Study (DONORS) was an open-label, parallel-group cluster randomized clinical trial in Brazil. Enrollment and follow-up were conducted from June 20, 2017, to November 30, 2019. Hospital ICUs that reported 10 or more brain deaths in the previous 2 years were included. Consecutive brain-dead potential donors in the ICU aged 14 to 90 years with a condition consistent with brain death after the first clinical examination were enrolled. Participants were randomized to either the intervention group or the control group. The intention-to-treat data analysis was conducted from June 15 to August 30, 2020.
INTERVENTIONS: Hospital staff in the intervention group were instructed to administer to brain-dead potential donors in the intervention group an evidence-based checklist with 13 clinical goals and 14 corresponding actions to guide care, every 6 hours, from study enrollment to organ retrieval. The control group provided or received usual care.
MAIN OUTCOMES AND MEASURES: The primary outcome was loss of brain-dead potential donors to cardiac arrest at the individual level. A prespecified sensitivity analysis assessed the effect of adherence to the checklist in the intervention group.
RESULTS: Among the 1771 brain-dead potential donors screened in 63 hospitals, 1535 were included. These patients included 673 males (59.2%) and had a median (IQR) age of 51 (36.3-62.0) years. The main cause of brain injury was stroke (877 [57.1%]), followed by trauma (485 [31.6%]). Of the 63 hospitals, 31 (49.2%) were assigned to the intervention group (743 [48.4%] brain-dead potential donors) and 32 (50.8%) to the control group (792 [51.6%] brain-dead potential donors). Seventy potential donors (9.4%) at intervention hospitals and 117 (14.8%) at control hospitals met the primary outcome (risk ratio [RR], 0.70; 95% CI, 0.46-1.08; P = .11). The primary outcome rate was lower in those with adherence higher than 79.0% than in the control group (5.3% vs 14.8%; RR, 0.41; 95% CI, 0.22-0.78; P = .006).
CONCLUSIONS AND RELEVANCE: This cluster randomized clinical trial was inconclusive in determining whether the overall use of an evidence-based, goal-directed checklist reduced brain-dead potential donor loss to cardiac arrest. The findings suggest that use of such a checklist has limited effectiveness without adherence to the actions recommended in this checklist.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03179020.
参考来源
- Westphal GA, Robinson CC, Giordani NE, et al. Evidence-Based Checklist to Delay Cardiac Arrest in Brain-Dead Potential Organ Donors: The DONORS Cluster Randomized Clinical Trial. JAMA Netw Open. 2023. PMID: 38095899. doi:10.1001/jamanetworkopen.2023.46901
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。